Business
VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care
About this update from Vsee Health, Inc.
[{"type":"text","content":"SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.Key Financial Highlights (Year-over-Year Comparisons)Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024Gross margin rose 2% to $7,355,965 from $7,177,580Operating expenses declined sharply by 76%The Company strengthened its balance sheet through multiple debt to equity conversionsCash and liquidity: Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024Key Business HighlightsDuring 2025 VSee Health focused on reducing public expenses associated with the IPO, and growth in its telehealth clinical services group.The company derived its 40% revenue growth by targeting large IDN's (Integrated Health Networks) in the USA. The team signed several large scale multi-year contracts (one for $10 million per year previously announced) in early and mid 2025. The telehealth revenue for new large healthcare institutional accounts takes several months to begin, as the operations are complex and must be integrated into VSee heath's technology before rolling out services. This is particularly important for our investors to understand that a majority of 2025 growth was in the second half of the year, and subsequently provides solid future growth in those accounts during 2026 as services continue to roll out to as many as 20 states this fiscal year. Management is bullish for 2026 growth as these contracts are continuing to build revenue and adding additional telehealth services.VSee Health continues to service government accounts such as NASA. In 2025 VSee Labs Inc was nominated and approved for Fedramp High status with the Federal Government as a technology partner. This was achieved through its HHS (Health and Human Services) contract awarded during 2024 and into 2025. VSee continues to pursue several government healthcare related projects in 2026.VSee Health experienced extremely high legal, accounting, and integration expenses associated with the IPO process in 2024 and 2025. The executive team w...